37 selected records with a cited source date in 2007. This archive is selective and does not imply continuous monitoring or complete historical coverage.
The Federal Register published notice E7-24812, attributed to FDA and its parent HHS department, on 2007-12-21. Its official title is “Pulmonary-Allergy Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Icatibant.
PeptideScanner retained PubMed bibliographic metadata for PMID 17955038 at 2026-07-30T22:40:22.998Z. PubMed recorded a metadata revision date of 2007-12-17 and an Entrez history date of 2007-10-24. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.
PeptideScanner retained ClinicalTrials.gov record NCT00534677 at 2026-07-30T22:39:13.109Z. Its registry update date was 2007-12-05, and PeptideScanner's reviewed identity mapping was octreotide.
PeptideScanner retained ClinicalTrials.gov record NCT00559338 at 2026-11-16T01:39:41.882Z. Its registry update date was 2007-11-16, and PeptideScanner's reviewed identity mapping was nesiritide.
PubMed lists PMID 10576957 in Clinical pharmacology and therapeutics as Journal Article, with publication-date metadata of 1999-09 (month precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PubMed lists PMID 15154998 in Journal of intensive care medicine as Editorial, Review, with publication-date metadata of 2004 May-Jun (source-text precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PubMed lists PMID 15500426 in Expert review of cardiovascular therapy as Comparative Study, Journal Article, Review, with publication-date metadata of 2004-11 (month precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PubMed lists PMID 16333235 in Minerva cardioangiologica as Comparative Study, Journal Article, Review, with publication-date metadata of 2005-12 (month precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PubMed lists PMID 16443809 in Critical care nurse as Case Reports, Journal Article, Review, with publication-date metadata of 2006-02 (month precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PubMed lists PMID 16503047 in Revue medicale suisse as English Abstract, Journal Article, Review, with publication-date metadata of 2006-01-25 (day precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PubMed lists PMID 16625824 in Current opinion in investigational drugs (London, England : 2000) as Journal Article, Review, with publication-date metadata of 2006-04 (month precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PubMed lists PMID 16999657 in Pharmacotherapy as Journal Article, Review, with publication-date metadata of 2006-10 (month precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PubMed lists PMID 2028837 in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research as Clinical Trial, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., with publication-date metadata of 1991-02 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PubMed lists PMID 6376042 in Deutsche medizinische Wochenschrift (1946) as Clinical Trial, English Abstract, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1984-06-15 (day precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PubMed lists PMID 15134286 in Current opinion in investigational drugs (London, England : 2000) as Journal Article, Review, with publication-date metadata of 2004-04 (month precision). PeptideScanner associated the retained record with the identity slug aod-9604. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
The Federal Register published notice E7-21886, attributed to FDA and its parent HHS department, on 2007-11-07. Its official title is “Lederle Laboratories et al.; Withdrawal of Approval of 73 New Drug Applications and 62 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Calcitonin salmon.
PeptideScanner retained PubMed bibliographic metadata for PMID 20641749 at 2026-07-30T22:40:23.016Z. PubMed recorded a metadata revision date of 2007-11-07 and an Entrez history date of 2007-11-07. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.
PeptideScanner retained ClinicalTrials.gov record NCT00191867 at 2026-07-30T22:39:13.109Z. Its registry update date was 2007-11-06, and PeptideScanner's reviewed identity mapping was teriparatide.
PeptideScanner retained ClinicalTrials.gov record NCT00190944 at 2026-07-30T22:39:13.107Z. Its registry update date was 2007-10-12, and PeptideScanner's reviewed identity mapping was teriparatide.
PeptideScanner retained ClinicalTrials.gov record NCT00532207 at 2026-07-30T22:39:13.109Z. Its registry update date was 2007-09-20, and PeptideScanner's reviewed identity mapping was teriparatide.
PeptideScanner retained ClinicalTrials.gov record NCT00532545 at 2026-07-30T22:39:13.108Z. Its registry update date was 2007-09-20, and PeptideScanner's reviewed identity mapping was teriparatide.
The official Drugs@FDA dataset lists original submission 1 for NDA 022074 with status AP dated 2007-08-30, and names lanreotide acetate among the application record's active ingredients.
The official Drugs@FDA dataset lists original submission 1 for ANDA 077372 with status AP dated 2007-08-14, and names octreotide acetate among the application record's active ingredients.
The official Drugs@FDA dataset lists original submission 1 for ANDA 077373 with status AP dated 2007-08-14, and names octreotide acetate among the application record's active ingredients.
PeptideScanner retained PubMed bibliographic metadata for PMID 15299336 at 2026-07-30T22:40:22.107Z. PubMed recorded a metadata revision date of 2007-07-24 and an Entrez history date of 1995-01-01. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.
PeptideScanner retained PubMed bibliographic metadata for PMID 15299335 at 2026-07-30T22:40:22.107Z. PubMed recorded a metadata revision date of 2007-07-24 and an Entrez history date of 1995-01-01. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.
PeptideScanner retained ClinicalTrials.gov record NCT00239629 at 2026-07-30T22:39:13.108Z. Its registry update date was 2007-06-12, and PeptideScanner's reviewed identity mapping was teriparatide.
PeptideScanner retained ClinicalTrials.gov record NCT00079924 at 2026-07-30T22:39:13.107Z. Its registry update date was 2007-05-25, and PeptideScanner's reviewed identity mapping was teriparatide.
PeptideScanner retained ClinicalTrials.gov record NCT00035256 at 2026-07-30T22:39:13.109Z. Its registry update date was 2007-05-15, and PeptideScanner's reviewed identity mapping was teriparatide.
The official Drugs@FDA dataset lists original submission 1 for NDA 022058 with status AP dated 2007-05-03, and names histrelin acetate among the application record's active ingredients.
The Federal Register published notice E7-4877, attributed to FDA and its parent HHS department, on 2007-03-19. Its official title is “Pediatric Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Octreotide.
PeptideScanner retained PubMed bibliographic metadata for PMID 17357189 at 2026-07-30T22:40:22.974Z. PubMed recorded a metadata revision date of 2007-03-14 and an Entrez history date of 2007-03-16. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.
PeptideScanner retained PubMed bibliographic metadata for PMID 17335137 at 2026-07-30T22:40:22.973Z. PubMed recorded a metadata revision date of 2007-03-05 and an Entrez history date of 2007-03-06. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.
PeptideScanner retained PubMed bibliographic metadata for PMID 16996699 at 2026-07-30T22:40:22.965Z. PubMed recorded a metadata revision date of 2007-02-23 and an Entrez history date of 2006-09-26. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.
PeptideScanner retained PubMed bibliographic metadata for PMID 2440061 at 2026-07-30T22:40:22.011Z. PubMed recorded a metadata revision date of 2007-01-29 and an Entrez history date of 1987-03-01. PeptideScanner associated this retained record with the identity slug emideltide. These dates describe PubMed metadata history, not the article's original publication date.
PeptideScanner retained ClinicalTrials.gov record NCT00191321 at 2026-07-30T22:39:13.108Z. Its registry update date was 2007-01-26, and PeptideScanner's reviewed identity mapping was teriparatide.
PeptideScanner retained ClinicalTrials.gov record NCT00191893 at 2026-07-30T22:39:13.108Z. Its registry update date was 2007-01-26, and PeptideScanner's reviewed identity mapping was teriparatide.